Companion Diagnostics Market

Companion Diagnostics Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

149

Base Year:

2022

Feb - 2023

Format:

Report Code:

VMR-2021

Segments Covered

By Product & Service Assays, Kits & Reagents, Software & Services
By Technology Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry, Other Technologies
By Indication Cancer, Neurological Disorders, Cardiovascular Disorders, Infectious Diseases, Other Indication
By End Users Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Other End Users
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 5.59 Billion
Revenue 2030:	USD 13.74 Billion
Revenue CAGR (2023 - 2030):	11.90%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Companion Diagnostics Market - Segment Analysis
1. Overview
2. Global Companion Diagnostics Market, 2016 - 2028 (USD Million)
3. Global Companion Diagnostics Market - by Product & Service
  1. By Assays
  2. By Kits & Reagents
  3. By Software & Services
4. Global Companion Diagnostics Market - by Technology
  1. By Next-Generation Sequencing
  2. By In Situ Hybridization
  3. By Immunohistochemistry
  4. By Other Technologies
5. Global Companion Diagnostics Market - by Indication
  1. By Cancer
  2. By Neurological Disorders
  3. By Cardiovascular Disorders
  4. By Infectious Diseases
  5. By Other Indication
6. Global Companion Diagnostics Market - by End Users
  1. By Pharmaceutical & Biopharmaceutical Companies
  2. By Reference Laboratories
  3. By Contract Research Organizations
  4. By Other End Users
7. Global Companion Diagnostics Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
8. Market comparative analysis
North America Companion Diagnostics Market - Segment Analysis
1. Overview
2. North America Companion Diagnostics Market, 2016 - 2028 (USD Million)
3. North America Companion Diagnostics Market, by Product & Service
  1. By Assays
  2. By Kits & Reagents
  3. By Software & Services
4. North America Companion Diagnostics Market, by Technology
  1. By Next-Generation Sequencing
  2. By In Situ Hybridization
  3. By Immunohistochemistry
  4. By Other Technologies
5. North America Companion Diagnostics Market, by Indication
  1. By Cancer
  2. By Neurological Disorders
  3. By Cardiovascular Disorders
  4. By Infectious Diseases
  5. By Other Indication
6. North America Companion Diagnostics Market, by End Users
  1. By Pharmaceutical & Biopharmaceutical Companies
  2. By Reference Laboratories
  3. By Contract Research Organizations
  4. By Other End Users
7. North America Companion Diagnostics Market, by Country
  1. U.S.
    1. U.S. Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. U.S. Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. U.S. Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. U.S. Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  2. Canada
    1. Canada Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. Canada Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. Canada Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. Canada Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  3. Mexico
    1. Mexico Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. Mexico Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. Mexico Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. Mexico Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
Europe Companion Diagnostics Market - Segment Analysis
1. Overview
2. Europe Companion Diagnostics Market, 2016 - 2028 (USD Million)
3. Europe Companion Diagnostics Market, by Product & Service
  1. By Assays
  2. By Kits & Reagents
  3. By Software & Services
4. Europe Companion Diagnostics Market, by Technology
  1. By Next-Generation Sequencing
  2. By In Situ Hybridization
  3. By Immunohistochemistry
  4. By Other Technologies
5. Europe Companion Diagnostics Market, by Indication
  1. By Cancer
  2. By Neurological Disorders
  3. By Cardiovascular Disorders
  4. By Infectious Diseases
  5. By Other Indication
6. Europe Companion Diagnostics Market, by End Users
  1. By Pharmaceutical & Biopharmaceutical Companies
  2. By Reference Laboratories
  3. By Contract Research Organizations
  4. By Other End Users
7. Europe Companion Diagnostics Market, by Country
  1. Germany
    1. Germany Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. Germany Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. Germany Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. Germany Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  2. UK
    1. UK Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. UK Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. UK Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. UK Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  3. France
    1. France Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. France Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. France Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. France Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  4. Spain
    1. Spain Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. Spain Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. Spain Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. Spain Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  5. Italy
    1. Italy Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. Italy Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. Italy Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. Italy Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  6. BENELUX
    1. BENELUX Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. BENELUX Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. BENELUX Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. BENELUX Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  7. Rest of Europe
    1. Rest Of Europe Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. Rest Of Europe Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. Rest Of Europe Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. Rest Of Europe Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
Asia Pacific Companion Diagnostics Market - Segment Analysis
1. Overview
2. Asia Pacific Companion Diagnostics Market, 2016 - 2028 (USD Million)
3. Asia Pacific Companion Diagnostics Market, by Product & Service
  1. By Assays
  2. By Kits & Reagents
  3. By Software & Services
4. Asia Pacific Companion Diagnostics Market, by Technology
  1. By Next-Generation Sequencing
  2. By In Situ Hybridization
  3. By Immunohistochemistry
  4. By Other Technologies
5. Asia Pacific Companion Diagnostics Market, by Indication
  1. By Cancer
  2. By Neurological Disorders
  3. By Cardiovascular Disorders
  4. By Infectious Diseases
  5. By Other Indication
6. Asia Pacific Companion Diagnostics Market, by End Users
  1. By Pharmaceutical & Biopharmaceutical Companies
  2. By Reference Laboratories
  3. By Contract Research Organizations
  4. By Other End Users
7. Asia Pacific Companion Diagnostics Market, by Country
  1. China
    1. China Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. China Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. China Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. China Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  2. Japan
    1. Japan Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. Japan Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. Japan Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. Japan Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  3. India
    1. India Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. India Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. India Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. India Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  4. South Korea
    1. South Korea Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. South Korea Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. South Korea Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. South Korea Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  5. South East Asia
    1. South East Asia Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. South East Asia Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. South East Asia Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. South East Asia Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. Rest of Asia Pacific Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. Rest of Asia Pacific Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. Rest of Asia Pacific Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
Latin America Companion Diagnostics Market - Segment Analysis
1. Overview
2. Latin America Companion Diagnostics Market, 2016 - 2028 (USD Million)
3. Latin America Companion Diagnostics Market, by Product & Service
  1. By Assays
  2. By Kits & Reagents
  3. By Software & Services
4. Latin America Companion Diagnostics Market, by Technology
  1. By Next-Generation Sequencing
  2. By In Situ Hybridization
  3. By Immunohistochemistry
  4. By Other Technologies
5. Latin America Companion Diagnostics Market, by Indication
  1. By Cancer
  2. By Neurological Disorders
  3. By Cardiovascular Disorders
  4. By Infectious Diseases
  5. By Other Indication
6. Latin America Companion Diagnostics Market, by End Users
  1. By Pharmaceutical & Biopharmaceutical Companies
  2. By Reference Laboratories
  3. By Contract Research Organizations
  4. By Other End Users
7. Latin America Companion Diagnostics Market, by Country
  1. Brazil
    1. Brazil Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. Brazil Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. Brazil Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. Brazil Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  2. Argentina
    1. Argentina Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. Argentina Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. Argentina Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. Argentina Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  3. Rest of Latin America
    1. Rest of Latin America Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. Rest of Latin America Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. Rest of Latin America Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. Rest of Latin America Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
Middle East & Africa Companion Diagnostics Market - Segment Analysis
1. Overview
2. Middle East & Africa Companion Diagnostics Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Companion Diagnostics Market, by Product & Service
  1. By Assays
  2. By Kits & Reagents
  3. By Software & Services
4. Middle East & Africa Companion Diagnostics Market, by Technology
  1. By Next-Generation Sequencing
  2. By In Situ Hybridization
  3. By Immunohistochemistry
  4. By Other Technologies
5. Middle East & Africa Companion Diagnostics Market, by Indication
  1. By Cancer
  2. By Neurological Disorders
  3. By Cardiovascular Disorders
  4. By Infectious Diseases
  5. By Other Indication
6. Middle East & Africa Companion Diagnostics Market, by End Users
  1. By Pharmaceutical & Biopharmaceutical Companies
  2. By Reference Laboratories
  3. By Contract Research Organizations
  4. By Other End Users
7. Middle East & Africa Companion Diagnostics Market, by Country
  1. GCC Countries
    1. GCC Countries Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. GCC Countries Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. GCC Countries Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. GCC Countries Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  2. South Africa
    1. South Africa Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. South Africa Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. South Africa Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. South Africa Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Companion Diagnostics Market, By Product & Service
      1. By Assays
      2. By Kits & Reagents
      3. By Software & Services
    2. Rest of Middle East & Africa Companion Diagnostics Market, By Technology
      1. By Next-Generation Sequencing
      2. By In Situ Hybridization
      3. By Immunohistochemistry
      4. By Other Technologies
    3. Rest of Middle East & Africa Companion Diagnostics Market, By Indication
      1. By Cancer
      2. By Neurological Disorders
      3. By Cardiovascular Disorders
      4. By Infectious Diseases
      5. By Other Indication
    4. Rest of Middle East & Africa Companion Diagnostics Market, By End Users
      1. By Pharmaceutical & Biopharmaceutical Companies
      2. By Reference Laboratories
      3. By Contract Research Organizations
      4. By Other End Users
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Abbott Laboratories Molecular Inc. (U.S.)
2. Agilent (Dako Denmark A/S) (U.S.)
3. ARUP Laboratories Inc. (U.S.)
4. BioMerieux (France)
5. Danaher Corporation (Leica Microsystems) (Germany)
6. Foundation Medicine Inc. (U.S.)
7. Myriad Genetics Inc. (U.S.)
8. Roche (Ventana Medical Systems Inc.) (U.S.)
9. Thermo Fisher Scientific (Life Technologies Corporation) (Germany)
10. QIAGEN N.V. (Germany)
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 28-Feb-2023

Companion Diagnostics Market to Reach Valuation of USD 10.3 Billion by 2028 – Advances in Next-Generation Sequencing Drives the Market

FAQ

Frequently Asked Question

What is the global demand for Companion Diagnostics in terms of revenue?

The global Companion Diagnostics valued at USD 5.59 Billion in 2022 and is expected to reach USD 13.74 Billion in 2030 growing at a CAGR of 11.90%.

Which are the prominent players in the market?

The prominent players in the market are Abbott Laboratories Molecular Inc. (U.S.), Agilent (Dako Denmark A/S) (U.S.), ARUP Laboratories Inc. (U.S.), BioMerieux (France), Danaher Corporation (Leica Microsystems) (Germany), Foundation Medicine Inc. (U.S.), Myriad Genetics Inc. (U.S.), Roche (Ventana Medical Systems Inc.) (U.S.), Thermo Fisher Scientific (Life Technologies Corporation) (Germany), QIAGEN N.V. (Germany).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 11.90% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Companion Diagnostics include
- Increased popularity of personalized medicine

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Companion Diagnostics in 2022.

Companion Diagnostics Market

Companion Diagnostics Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Companion Diagnostics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Companion Diagnostics Market

Companion Diagnostics Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Companion Diagnostics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Companion Diagnostics Market

Vantage Point Interactive Dashboard